Chicago, Feb. 7 – JPMorgan Chase Financial Co. LLC priced $1.4 million of 0% capped buffered enhanced participation equity notes due Nov. 1, 2023 linked to the SPDR S&P Biotech ETF, according to a 424B2 filing with the Securities and Exchange Commission.
The notes are guaranteed by JPMorgan Chase & Co.
If the ETF return greater than the initial level, the payout at maturity will be par plus 1.5 times the ETF return, subject to a maximum settlement amount of par plus 36.9%.
If the ETF return is flat, or greater than or equal to the 85% buffer level, investors will receive par.
If the ETF falls by more than 10%, investors will lose 1.1765% for each 1% decline beyond the 15% buffer.
J.P. Morgan Securities LLC is the agent.
| Issuer: | JPMorgan Chase Financial Co. LLC
|
| Guarantor: | JPMorgan Chase & Co.
|
| Issue: | Capped buffered enhanced participation equity notes
|
| Underlying ETF: | SPDR S&P Biotech ETF
|
| Amount: | $1,400,000
|
| Maturity: | Nov. 1, 2023
|
| Coupon: | 0%
|
| Price: | Par
|
| Payout at maturity: | If ETF gains, par plus 1.5 times the gain, capped at par plus 36.9%; if the ETF is flat, or greater than or equal to the 85% buffer level, par; if the ETF falls below the 15% buffer, investors will lose 1.1765% for each 1% decline beyond 15%
|
| Initial level: | $73.83.
|
| Buffer level: | 85% of initial ETF level
|
| Pricing date: | April 29, 2022
|
| Settlement date: | May 6, 2022
|
| Agent: | J.P. Morgan Securities LLC
|
| Fees: | 1.51%
|
| Cusip: | 48133FUQ6
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
